Furthermore, the SNHG26‐CDKN2A axis modulated the tumour immune microenvironment by regulating CD8+ T cell cytotoxicity and chemokine expression, specifically downregulating CXCL9 and CXCL10, which are critical for T cell recruitment. The gene discussed is CXCL9; the disease is neoplasm.